Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.

Autor: Karagiannis T; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece. tkaragian@auth.gr.; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece. tkaragian@auth.gr., Malandris K; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Avgerinos I; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Stamati A; School of Medicine, Faculty of Health Science, Aristotle University of Thessaloniki, Thessaloniki, Greece., Kakotrichi P; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Liakos A; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Vasilakou D; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Kakaletsis N; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece., Tsapas A; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.; Harris Manchester College, University of Oxford, Oxford, UK., Bekiari E; Clinical Research and Evidence-Based Medicine Unit, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.; Diabetes Centre, Second Medical Department, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Publikováno v: Diabetologia [Diabetologia] 2024 Jul; Vol. 67 (7), pp. 1206-1222. Date of Electronic Publication: 2024 Apr 13.

Clinical presentation and diagnostic evaluation of pheochromocytoma: case series and literature review.

Autor: Anyfanti P; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Mastrogiannis Κ; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Lazaridis Α; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Tasios Κ; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Vasilakou D; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Kyriazidou Α; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Aroutsidis F; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Pavlidou O; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Papoutsopoulou Ε; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Tiritidou A; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Kotsis V; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Triantafyllou Α; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Zarifis Ι; Department of Cardiology, Papanikolaou General Hospital, Thessaloniki, Greece., Douma S; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Gkaliagkousi Ε; 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Publikováno v: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2023 Dec 31; Vol. 45 (1), pp. 2132012. Date of Electronic Publication: 2022 Oct 11.

Long‐term effects of ipragliflozin and pioglitazone on metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes: 5 year observational follow‐up of a randomized, 24 week, active‐controlled trial: Effect of ipragliflozin in MASLD

Autor: Ito, Daisuke^1,2 (AUTHOR) dito@saitama-med.ac.jp, Shimizu, Satoshi² (AUTHOR), Haisa, Akifumi^1,2 (AUTHOR), Yanagisawa, Shinnosuke^1,2,3 (AUTHOR), Inoue, Kazuyuki^1,2 (AUTHOR), Saito, Daigo^1,2 (AUTHOR), Sumita, Takashi^1,2 (AUTHOR), Yanagisawa, Morifumi³ (AUTHOR), Uchida, Yoshihito⁴ (AUTHOR), Inukai, Kouichi⁵ (AUTHOR), Shimada, Akira¹ (AUTHOR)

Publikováno v: Journal of Diabetes Investigation. Sep2024, Vol. 15 Issue 9, p1220-1230. 11p.

New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions.

Autor: Chatzianagnostou, Kyriazoula¹ (AUTHOR) zulachat@ftgm.it, Gaggini, Melania² (AUTHOR) melania.gaggini@cnr.it, Suman Florentin, Adrian² (AUTHOR) adriansumanflorentin@gmail.com, Simonini, Ludovica³ (AUTHOR) simoniniludovica@gmail.com, Vassalle, Cristina¹ (AUTHOR) cristina.vassalle@ftgm.it

Publikováno v: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 11, p6218. 28p.

Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24‐week, randomized, double‐blind, active‐controlled, phase 3 trial.

Autor: Xie, Lingding¹ (AUTHOR), Han, Jie² (AUTHOR), Cheng, Zhifeng³ (AUTHOR), Liu, Dexue⁴ (AUTHOR), Liu, Jie⁵ (AUTHOR), Xu, Chunrong⁶ (AUTHOR), Sun, Wenli⁷ (AUTHOR), Li, Qingju⁸ (AUTHOR), Bian, Fang⁹ (AUTHOR), Zhang, Wei¹⁰ (AUTHOR), Chen, Jinyu¹⁰ (AUTHOR), Zhu, Qian¹⁰ (AUTHOR), Thurber, Tara K.¹¹ (AUTHOR), Lock, J. Paul¹² (AUTHOR), Zhang, Bo¹ (AUTHOR) drbozhang@yahoo.com

Publikováno v: Journal of Diabetes. Apr2024, Vol. 16 Issue 4, p1-13. 13p.